
A survey of more than 1600 cancer victims has revealed that cancer patients in the UK are not only battling the disease, but are also worried about mounting costs as they need to spend hundreds of pounds a month.
The ones suffering the most are those who have children to take care and also have huge mortgages to pay.
Advertisement
Some of them are unable to work due to the condition. This results in loss of income. On an average 83% of victims incurred costs close to about £270 a month.
Attending hospital appointments and transportation proved quite costly. About 22% of the victims said that medicines were expensive.
Macmillan Cancer Support chief executive Ciaran Devane said: "This new research shows that cancer comes with a whopping price tag for many patients."
"Combined with the current recession and with welfare cuts, the cost of the disease is hitting the most vulnerable hardest. With the number of people living with cancer in the UK doubling from two to four million by 2030, this is a growing problem which cannot be ignored."
The charity is of the opinion that the government, NHS and business houses must come forward to help people with cancer.
Source: Medindia
Macmillan Cancer Support chief executive Ciaran Devane said: "This new research shows that cancer comes with a whopping price tag for many patients."
Advertisement
"Combined with the current recession and with welfare cuts, the cost of the disease is hitting the most vulnerable hardest. With the number of people living with cancer in the UK doubling from two to four million by 2030, this is a growing problem which cannot be ignored."
The charity is of the opinion that the government, NHS and business houses must come forward to help people with cancer.
Source: Medindia
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News

The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.

Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.

The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.

Mutations in 11 genes are linked to aggressive forms of prostate cancer, which may present novel therapeutic and therapy options.

Improved oral health, as indicated by the count of natural teeth and dental appointments preceding the diagnosis, correlated with enhanced head and neck cancer survival rates.